subject: Aarkstore Enterprise---cytocore, Inc. (cyoe) - Financial And Strategic Analysis Review [print this page] CytoCore, Inc. (CytoCore) is a life sciences company involved in designing, developing and commercializing cost-effective screening systems for the early detection of cancer. The major product developed by the company is CytoCore Solutions System, a simple and cost-effective method to screen women for endometrial cancer. It is comprised of four distinct components namely the SoftPAP cervical cell collector, the AIPS microscope platform, drug delivery system for treating cervical lesions, and a protein-based biochemical cocktails and Slide Based Tests. The company is headquartered in Illinois, United States.
CytoCore, Inc. Key Recent Developments
Feb 27, 2010: UCLA Selects PadKit Collection System For Cervical Cancer Study
Aug 19, 2009: CytoCore Reports Q2 2009 Results
May 18, 2009: CytoCore Posts Net Loss Of $1.9 Million In Q1 2009
Apr 16, 2009: CytoCore Signs Agreement With Amsino
Mar 31, 2009: CytoCore Posts Net Loss Of $6.3 Million In 2008
This comprehensive SWOT analysis of CytoCore, Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including,
- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
